docetaxel anhydrous has been researched along with Raynaud Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amoura, Z; Barbaud, A; Francès, C; Mathian, A; Monfort, JB; Senet, P | 1 |
1 other study(ies) available for docetaxel anhydrous and Raynaud Disease
Article | Year |
---|---|
[Cancers associated with systemic sclerosis involving anti-RNA polymerase III antibodies].
Topics: Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Autoantigens; Carcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Radiotherapy, Adjuvant; Raynaud Disease; Remission Induction; RNA Polymerase III; Scleroderma, Systemic; Taxoids; Tonsillectomy; Young Adult | 2018 |